We are live on ! Find out more
VIGL

Vigil Neuroscience

Delisted

VIGL was delisted on the 4th of August, 2025.

54 hedge funds and large institutions have $90.5M invested in Vigil Neuroscience in 2024 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 10 increasing their positions, 15 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 3

17% more funds holding

Funds holding: 4654 (+8)

7% more capital invested

Capital invested by funds: $84.6M → $90.5M (+$5.99M)

2.16% more ownership

Funds ownership: 69.73%71.89% (+2.2%)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

33% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 15

Holders
54
Holders Change
+8
Holders Change %
+17.39%
% of All Funds
0.78%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
12
Increased
10
Reduced
15
Closed
3
Calls
Puts
Net Calls
Net Calls Change

VIGL Hedge Fund Activity: Q1 2024 in Review

54 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Vigil Neuroscience (VIGL) for Q1 2024, worth a combined $90.5M — up 7.1% from $84.6M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new VIGL positions and 3 closed out — a net gain of 9 holders — while 10 added to existing stakes and 15 trimmed.

The largest buyer was Sphera Funds Management, adding an estimated $3.73M. The largest seller was Anson Funds Management, exiting entirely with an estimated $700K sold.

  • 54 institutional investors held Vigil Neuroscience (VIGL) as of Q1 2024, up from 46 in Q4 2023.
  • Funds reported $90.5M of Vigil Neuroscience stock for Q1 2024, up 7.1% quarter-over-quarter.
  • 12 funds opened new Vigil Neuroscience positions in Q1 2024 and 3 closed out, a net change of +9 holders.
  • The largest Vigil Neuroscience buyer in Q1 2024 was Sphera Funds Management, an estimated $3.73M added.
  • The largest Vigil Neuroscience seller in Q1 2024 was Anson Funds Management, an estimated $700K sold.

Based on aggregated 13F filings for Q1 2024.